Galderma Continues Global Growth Ambition With Sculptra® (injectable poly-L-lactic Acid) Re-launch in Europe
Galderma today announced a European re-launch of Sculptra ® (injectable poly-L-lactic acid) - a collagen stimulator - with an updated administration protocol. This means that the product is ready for use more quickly following reconstitution, with increased levels of comfort for patients. Sculptra ® can now be used immediately following a two-minute reconstitution and with the optional addition of lidocaine for patient comfort. Previously, healthcare professionals had to wait two hours following reconstitution to administer the product. Sculptra ® now has the fastest reconstitution protocol of any injectable poly-L-lactic acid (PLLA) available in Europe, representing a significant growth opportunity for Galderma.
“Sculptra ® has been my go-to tool for treating skin laxity resulting from aging and collagen loss in my patients’ skin, helping restore a youthful appearance,” said Dr. Christoph Martschin, Dermatologist, Akademikliniken, Department of Dermatology, Stockholm, and a featured speaker at the Sculptra ® European re-launch virtual event. “This new reconstitution protocol for Sculptra ® represents an exciting benefit as we are able to save valuable clinic time for clinicians while improving overall procedure comfort for our patients.”
Collagen provides structure and support to the skin. With facial aging, the skin’s natural collagen supply may decrease and could lead to skin laxity, wrinkles and roughness as skin quality worsens.1,2 Sculptra ® is a collagen stimulator that may help replenish lost collagen by gradually stimulating and increasing an individual’s own natural collagen production, helping restore skin quality and firmness.2-5
The updated protocol is based on new data from physiochemical studies,6 as well as results from a randomized, evaluator-blinded, parallel-group, multi-center study (NCT03780244) evaluating the safety and effectiveness of two different dilutions of Sculptra ®. This study demonstrated that treatment immediately following a two-minute reconstitution using the higher reconstitution volume (9 mL including lidocaine) was well tolerated, caused less pain on injection and was comparable to that of the reference group (Sculptra ® 5 mL) in reducing wrinkle severity of nasolabial folds (NLF) at Week 48 (n=80). Additionally, the mean change in wrinkle assessment scale (WAS) from baseline (assessed by Blinded Evaluator) was similar in both Sculptra ® study groups across 48 weeks and investigator assessed improvement using the Global Aesthetic Improvement Scale (GAIS) was > 90% in both Sculptra ® study groups.
As part of this European re-launch and in line with the company’s intensified commitment to Sculptra ®, Galderma held a dedicated interactive, virtual event with over 1,000 healthcare professionals to provide additional training and support related to this new administration protocol. The event also facilitated best practice sharing among physicians based on their clinical experiences.
“We are delighted to bring this expanded Sculptra ® offering to healthcare professionals in Europe, and yesterday’s launch event was an exciting, well-attended re-introduction to Sculptra ® and Galderma’s larger aesthetics portfolio,” said Alexandre Brennan, Global Business Unit Head, Aesthetics. “We continue to build a unique and extensive aesthetics offering at Galderma, and are proud to re-launch Sculptra ® in Europe as the foundation of our portfolio alongside a range of complementary treatments to deliver impressive and long-lasting results for healthcare professionals and their patients.”
Sculptra ® was first approved in Europe in 1999, in the United States in 2009 and in Brazil in 2004. Sculptra ® is now available in more than 40 countries globally, and additional regulatory reviews of applications for Sculptra ® in various regions are ongoing.
About Sculptra
®
Sculptra
® works to stimulate the skin’s own collagen production and is suitable for increasing the volume of depressed areas, particularly to correct skin depressions such as skin creases, wrinkles, folds, scars and for skin aging. Sculptra
® is also suitable for large volume corrections of the signs of facial fat loss (lipoatrophy).
Sculptra ® is an injectable biostimulator containing microparticles of Poly-L-Lactic Acid (PLLA) which gradually revitalizes the skin’s structural foundation, providing natural-looking, long-term results for up to 25 months. Sculptra ® was first approved in 1999 in Europe and it is currently available in more than 40 countries globally. To learn more about Sculptra ® products, visit www.galdermaaesthetics.com
About Galderma
Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in approximately 100 countries with an extensive product portfolio of prescription medicines, aesthetic solutions and consumer care products. The company partners with healthcare professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin. For more information, please visit www.galderma.com
- Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 1975;93:639-643.
- Bohnert K et al. Plast Reconstr Surg 2019;127(4):1684–92.
- Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.
- Goldberg D et al. Dermatol Surg 2013;39(6):915–22.
- Vleggaar D et al. J Drugs Dermatol 2014;13 (4 suppl):s29–31.
- Baumann K et al. J Drugs Dermatol. 2020;19(12):1199-1203.
###
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210303006096/en/
Contact information
Investor and media relations
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50
Media Contact
Lauren Starr
Head of Franchise Communications
media@galderma.com
+41 79 771 52 45
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Codethink Achieves Positive Functional Safety Assessment to IEC 61508 and ISO 26262 Standards for the Eclipse Trustable Software Framework30.10.2025 11:04:00 EET | Press release
Codethink announced that it has successfully achieved a positive and complete Functional Safety Assessment for the Eclipse Trustable Software Framework (TSF). Performed by exida, a globally recognised authority in functional safety, the assessment was conducted in accordance with IEC 61508 requirements, with domain experts ensuring full alignment and compatibility with ISO 26262, the automotive industry’s functional safety standard. The evaluation represents a major milestone in Codethink’s mission to transform how the world engineers, verifies, and trusts software. According to the assessment, “considering the process objectives of both IEC 61508 and ISO 26262, the specification of Trustable [Trustable Software Framework] and the reference implementation that maps Trustable tenets and assertions to the objectives in IEC 61508, it is determined that Trustable sets out an approach to software development which meets and in many cases exceeds the rigor and expectations established for so
GHK Capital-Backed Horizon Group Welcomes Kasper Diaz Sommer as Senior Vice President of Global Cruise Logistics30.10.2025 11:00:00 EET | Press release
Horizon Group, along with its subsidiaries Swift Marine and Delver Agents, proudly announces the appointment of Kasper Diaz Sommer as Senior Vice President (SVP) of Global Cruise Logistics, effective November 3, 2025. Based in Denmark, Kasper will lead the group’s global Cruise Logistics strategy, driving growth across Europe, Asia, and the Americas and strengthening Horizon’s role as the trusted logistics partner to the world’s leading marine and cruise operators. With over two decades of international leadership experience in freight forwarding, logistics, and maritime supply chains, Kasper is known for his hands-on leadership, customer-first mindset, and proven success in building high-performing global teams. “Kasper’s leadership will accelerate our strategy to deliver seamless, end-to-end logistics solutions for the world’s marine and cruise operators,” said Jeff McCorstin, CEO of Horizon. “His industry insight, strategic mindset, and passion for innovation align perfectly with ou
Ares Management to Acquire BlueCove30.10.2025 10:18:00 EET | Press release
Ares Management Corporation (NYSE: ARES) (“Ares”) announced today that one of its affiliates has entered into a definitive agreement to acquire the entire outstanding share capital of BlueCove Limited (“BlueCove”), a London-based systematic fixed income manager. Financial terms were not disclosed. The transaction is expected to close in the first quarter of 2026, subject to customary closing conditions, including regulatory approvals. Founded in 2018 by Alex Khein and Hugh Willis – who have respectively served as CEO and Executive Chairman – BlueCove has grown to become a leader in systematic credit investing. The firm is comprised of a highly experienced, long-tenured team of fixed income investment, engineering, and business infrastructure professionals specializing in systematic portfolio management. Through its proprietary technology and varied product offering, BlueCove invests in high-yield, corporate investment grade, convertible bonds, and other liquid credit instruments. Since
Manhattan Associates Announces Appointment of Greg Betz As Chief Operating Officer30.10.2025 10:00:00 EET | Press release
Manhattan Associates Inc. (NASDAQ: MANH) today announced the appointment of Greg Betz to the position of Chief Operating Officer. A seasoned executive, Betz brings broad experience leading complex, international organisations. Most recently, Greg led Microsoft FastTrack, an organisation of more than 1,000 engineers in 35 countries that deliver cloud conversions to Microsoft's largest cloud customers. “Greg is an accomplished executive with a proven track record of delivering operational excellence to transform businesses and drive growth,” said Eric Clark, president and CEO of Manhattan Associates. “His appointment is yet another proof point of our commitment to expanding the depth and experience of our team to drive faster cloud adoption, and I am confident that his forward-thinking, result-oriented approach will play a pivotal role in our next phase of rapid growth.” In his new position, Greg will play a key role in helping scale the operational frameworks around conversions and rene
Bybit Expands Partnership with Thredd to Globally Scale Multi-Currency Crypto-Linked Debit Cards30.10.2025 10:00:00 EET | Press release
Thredd, the leading next-generation global payments processor, today announced an expanded partnership with Bybit, the world’s second-largest cryptocurrency exchange by trading volume. The collaboration supports regional rollout of the Bybit Card—Bybit’s flagship multi-currency, crypto-linked payment card, bridging the gap between digital assets and everyday payments across key global markets. Thredd’s processing platform is built to scale and navigate regulatory requirements across regions. With a single connection, Bybit can configure market-specific programs that meet local compliance needs while retaining centralized visibility. This flexibility has enabled Bybit to rapidly expand across multiple markets with more on the horizon. Over 2 million users worldwide trust the Bybit Card for what matters most: competitive cardholder rewards, true global access, and effortless crypto-to-fiat convenience. Bybit leverages Thredd’s infrastructure to issue both virtual and physical Visa and Ma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom